Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    MitoQ
Show Display Options
Rank Status Study
1 Completed A Trial of MitoQ for the Treatment of People With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: MitoQ
2 Terminated A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Drug: Mitoquinone mesylate;   Drug: Placebo
3 Completed Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Mitoquinone mesylate (MitoQ)
4 Not yet recruiting Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Interventions: Dietary Supplement: MitoQ;   Dietary Supplement: Placebo

Indicates status has not been verified in more than two years